| 29-Mar-2012 | S | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 29, 2012, inter alia, have taken (subject to approval of members by way of Postal Ballot) the following decisions:
Sub-division of Equity Shares of Rs. 10/- each to Rs. 2/-each.
SUB: Sub Division and Bonus issue of equity shares of Indoco Remedies Ltd. (Scrip Code 532612)
Trading Members of the Exchange are hereby informed that, Indoco Remedies Ltd. has fixed the Record Date for the purpose of sub division and bonus issue.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME CODE
Indoco Remedies Ltd.
(532612)
RECORD DATE
19.05.2012
PURPOSE
Sub Division of existing equity shares from every 1 (ONE) equity share of Rs. 10/- (TEN) each into 5 (FIVE) equity shares of Rs. 2/- (TWO) each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE & EX-BONUS W.E.F.
17/05/2012 DR-034/2012- 2013
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 17/05/2012.
ii. ISIN No. INE873D01016 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 17/05/2012.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 10.05.2012) | 19-May-2012 | |
| 23-May-2023 | D | Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 23rd May, 2023 has inter-alia considered and approved the following.
2. Subject to the approval of the Members at the ensuing 76th Annual General Meeting, recommended a Dividend of Rs. 2.25 per equity share on face value of Rs. 2/- for the financial year 2022-2023.
Pursuant to Regulation 42 of SEBI(LODR) Regulations, 2015, the Company has fixed Tuesday, 19th September, 2023 as the Record Date.
(As Per BSE Announcement Dated on 01/09/2023)
| 18-Sep-2023 | |
| 17-May-2022 | D | We wish to inform that the Board of Directors of the Company at its meeting held today i.e. 17-05-2022 has interalia considered and approved the following:
Subject to the approval of the Members at the ensuing 75th AGM, recommended a Dividend of Rs.2.25 per share (including a Special Dividend of Rs. 0.75) on face value of Rs. 2/- for the Financial year 2021-2022. | 14-Sep-2022 | |
| 17-May-2022 | D | We wish to inform that the Board of Directors of the Company at its meeting held today i.e. 17-05-2022 has interalia considered and approved the following:
Subject to the approval of the Members at the ensuing 75th AGM, recommended a Dividend of Rs.2.25 per share (including a Special Dividend of Rs. 0.75) on face value of Rs. 2/- for the Financial year 2021-2022. | 14-Sep-2022 | |
| 25-May-2021 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2021, inter alia, has recommended dividend of Rs. 1.50/- per share (75%) on face value of Rs. 2/- each for the financial year 2020-2021, subject to the Members approval at the AGM.
Dividend for the year 2020-2021 | 17-Sep-2021 | |
| 24-Jun-2020 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 24, 2020, inter alia, has recommended dividend of Rs.0.30/ - per share (15%) on face value of Rs. 2/- each for the financial year 2019-2020,subject to the Members approval at the AGM. | 18-Sep-2020 | |
| 29-May-2019 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 29, 2019, inter alia, has recommended dividend of Rs. 0.30/- per share (15%) on face value of Rs. 2/- each for the financial year 2018-19, subject to the Members approval at the AGM. | 22-Aug-2019 | |
| 30-May-2018 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2018, inter alia, have recommended final Dividend of Rs. 1.00/- per share (50%) on face value of Rs. 2/- each for the financial year 2017-18. | 31-Aug-2018 | |
| 26-May-2017 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2017, inter alia, have recommended final dividend of Rs. 1.60/- per share of face value of Rs.2 each for the financial year 2016-17. The dividend, if approved by the Members, will be dispatched/remitted on or after August 14, 2017 after the ensuing Annual General Meeting. | 31-Jul-2017 | |
| 27-May-2016 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, inter alia, have recommended dividend of Rs. 0.20 per share on face value of Rs. 2/- per share (10%) for the year 2015-16, which will be paid on or after August 03, 2016 subject to approval by the shareholders at the 69th Annual General Meeting.
The Meeting of the Board of Directors commenced at 10.30 a.m. and concluded at 12.15 p.m. | 20-Jul-2016 | |
| 10-Mar-2016 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2016, has decided to declare an interim dividend of Rs. 1.40 per share (70%) for the financial year 2015-16. | 17-Mar-2016 | |
| 27-May-2015 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2015, inter alia, has approved the following:
1. payment of final divided of Rs. 1.60 per equity share on the face value of Rs. 2/- each i.e. 80% for financial year 2014-15 subject to approval of members. The dividend when approved at the AGM will be paid on or after August 05, 2015 to those shareholders whose names appear on the register of members as on the record date. | 21-Jul-2015 | |
| 28-May-2014 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2014, inter alia, have recommended a dividend of 70% i.e. Rs. 1.40 per equity share of face value of Rs. 2/- each for the year 2013-14 subject to the approval of shareholders in the ensuing Annual General Meeting. | 21-Jul-2014 | |
| 28-May-2013 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2013, inter alia, has recommended payment of dividend of Rs.1.10 per equity share on the face value of Rs. 2/- each i.e. 55% for financial year 2012-13. The dividend when approved at the AGM will be paid on or after August 05, 2013 to those shareholders whose names appear on the register of members as on the record date.4 | 19-Jul-2013 | |
| 28-May-2012 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2012, inter alia, has recommended payment of divided of Rs. 1.10 per equity share on the face value of Rs. 2/- each i.e. 55% for financial year 2011-12 subject to the approval of members in the ensuing Annual General Meeting. | 20-Jul-2012 | |
| 28-May-2011 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2011, inter alia, decided to recommend a dividend of Rs. 8/- per equity share of Rs. 10/- each of the Company (80%) for the year ended March 31, 2011. The dividend when approved at the AGM will be paid on or after August 08, 2011 to those shareholders whose names appear on the register of members as on the record date. | 19-Jul-2011 | |
| 31-May-2010 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2010, inter alia, recommended payment of divided of Rs. 7.00 per equity share i.e. 70% for financial year 2009-10 subject to the approval of members in the ensuing Annual General Meeting. | 13-Jul-2010 | |
| 30-Jul-2009 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 30, 2009, inter alia, has decided to declare a final dividend of Rs 2.00 per equity share (20%). | 09-Sep-2009 | |
| 26-Nov-2008 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 26, 2008, has decided to declare an interim dividend of Rs 3.25 per share (32.5%) for the financial year 2008-09. | 11-Dec-2008 | |
| 05-Sep-2008 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 05, 2008, inter alia, has confirmed the proposal for recommendation of a dividend of Rs 5.00 per share (50%) for the financial year ended March 31, 2008 (9 months). | 19-Sep-2008 | |
| 18-Oct-2007 | D | Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 18, 2007, inter alia, has proposed a dividend of 65% for the financial year 2006-07. | 13-Dec-2007 | |
| 28-Apr-2006 | D | 50% Dividend | 15-Sep-2005 | |
| 09-May-2012 | B | SUB: Bonus issue of equity shares of Indoco Remedies Ltd. (Scrip Code 532612)
Trading Members of the Exchange are hereby informed that, Indoco Remedies Ltd. has fixed the Record Date for the purpose of bonus issue.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME CODE
Indoco Remedies Ltd.
(532612)
RECORD DATE
19.05.2012
PURPOSE
Issue of 1 (ONE) bonus equity share of Rs. 2/- (TWO) each for every 2 (TWO) equity shares of Rs. 2/- (TWO) held.
EX-BONUS W.E.F.
17/05/2012 DR-034/2012- 2013
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 17/05/2012.
ii. ISIN No. INE873D01016 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 17/05/2012.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 10.05.2012) | 17-May-2012 | 1:2 |
| 15-Apr-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda | 16-Apr-2024 | |
| 23-Jan-2024 | BC | Appointment of Mr. Ajay Mulgaonkar and Mr. Satish Shenoy as a Additional Independent Director of the Company for a term of 5 years w.e.f. 01st April 2024 to 31st March 2029 subject to the approval of | 01-Apr-2024 | |
| 29-Mar-2024 | BC | Mr. Divakar Gavaskar and Mr. Rajiv Kakodkar shall cease to be an Independent Directors of the Company upon completion of two(2) consecutive terms of five(5) years each at the closure of business hour | 31-Mar-2024 | |
| 29-Mar-2024 | BC | The Board of Directors in its meeting held today i.e. 29th March, 2024 has interalia considered and approved the re-appointment of following auditors for the financial year 2024-2025. 1. M/s A.Y.Sath | 29-Mar-2024 | |
| 10-Jan-2024 | BC | INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the Securitie | 23-Jan-2024 | |